Math 105--Calculus I: Project 1, Spring 1996

...A question of alertness

by Gavin LaRose (glarose@umich.edu), Nebraska Wesleyan University, January 1996

©1996 Gavin LaRose (glarose@umich.edu)
permission granted to use and distribute free in an academic setting

You are recently hired members of a successful independent mathematical and scientific technical contracting company, and have just been assigned your first contract. The letter you received from Medres, Inc., a medical research company said to have been recently acquired by the world-wide MPC, Inc. conglomerate (the recently expanded headquarters of which are to be found in the thriving metropolis of Lonlinc, Skanebra), follows.

plain TeX file with project
PostScript version of project

The letter...

Medres, Inc.


Office 728 Ratherold Hall
325 Eep Street
Lonlinc, SK 04685

29 January, 1996

Independent Mathematical Contractors, Inc.
Suite 2, Strawmarket Business Plaza
Lonlinc, SK 04685

Dear IMC:

Medres, Inc., always at the cutting edge of medical research, is planning the announcement of a major breakthrough by its pharmaceutical development division on the 14th of February. We have completed the manufacture and testing of a time-release capsule which will consistently and safely release the proven stimulent enieffac into the taker's bloodstream over an eight-hour period, to produce alertness and combat the effects of missed sleep.

Experimentally, we have observed that after taking one of our capsules, the amount of enieffac in the bloodstream is given by the following data:

t= 0 hr .1 hr .5 hr 1 hr 2 hr 5 hr 8 hr 8.5 hr 9 hr
c(t) = 2.01 mg 1.58 mg 1.06 mg 1 mg 1 mg 1 mg 1 mg .02 mg .01 mg

In order to report completely on the drug, we need a function to model this concentration data. We have therefore contracted with your company to develop such a model. In addition, we also need to know, based on the function you find, how long it takes for the initial spike in enieffac concentration to decrease to within .1 mg of its long-term value.

As our product announcement is scheduled for the 14th of February, it is of utmost importance that we have your finished project report by the 12th of that month. If you have questions as you are working on the project, you should confer with our chief consultant, Dr. Gavin LaRose, who has been instructed to assist you insofar as may be possible (as he is currently under contract with the well-known chemical reprocessing company Chemproc, Inc., he is unfortunately unable to work full-time on this project--thus requiring our use of your company). Please also note that it is written into your contract that you contact him by the 2nd of January with your investigative team to appraise him of your progress on the project. Failure to do so will result in a significant payment penalty. As is usual, we have enclosed a copy of our technical report specifications, which should govern the presentation of your results.

Yours sincerely,
Cever Etkoop, M.D.
President, Medres, Inc.

Encl: Technical report requirements


The technical specifications...

Medres, Inc.


M.P.C., Inc. Technical Report Requirements

All reports submitted to Medres, Inc. should be written so that all members of the board of directors can understand the issues raised therein and therefore be able to appropriately use the report. The board members are all experts in various medical fields, but unfortunately (though they all wish they had taken more) may only be expected to have a background in precalculus mathematics.

Reports should further:


[Left Arrow]Back to Calc Projects Page


last modified on 4 Jul 1996

Gavin's Calc I Project 1, Spring 1996
Comments to: glarose@umich.edu